Senator Elizabeth Warren Proposes Bill to Hold Private Equity Executives Accountable for Patient Deaths
Senator Elizabeth Warren has introduced a bill aimed at holding private equity executives accountable for patient deaths resulting from their financial decisions. The Corporate Crimes Against Health Care Act of 2026 would create criminal penalties for executives whose actions lead to patient harm, marking a significant shift in the regulation of the private equity industry.
The bill comes in response to the collapse of Steward Health Care, a private equity-owned hospital chain that shuttered facilities, eliminated jobs, and left communities without access to emergency care. Warren and a coalition of Democratic lawmakers argue that private equity executives have prioritized profits over patient care, leading to devastating consequences.
Private Equity's Role in Healthcare
Private equity firms have been increasingly involved in the healthcare industry, buying thousands of facilities, including rural hospitals, non-profit hospice operations, and small-town dental offices. However, research has shown that hospitals acquired by private equity experience higher rates of hospital-acquired adverse events, including central line-associated bloodstream infections, patient falls, and surgical site infections.
A study analyzing over 4.1 million Medicare hospitalizations found that private equity-acquired hospitals had around 25% more hospital-acquired adverse events compared to others. Another study found that patient care experience worsened after private equity acquisition, particularly in patient-reported staff responsiveness.
Consequences of Private Equity's Actions
The consequences of private equity's actions in the healthcare industry are far-reaching. When private equity-backed companies collapse, they often leave behind a trail of debt and financial distress. This can lead to a loss of essential services, including emergency care, and can have devastating consequences for communities.
According to the Private Equity Stakeholder Project, private equity-backed companies accounted for most major U.S. corporate bankruptcies in 2025 and the first half of 2026. The group also notes that over 60% of large manufacturing bankruptcies last year were backed by private equity.
Warren's Bill: Holding Executives Accountable
Warren's bill would impose up to six years in prison for executives who "loot health care entities like nursing homes and hospitals, if that looting results in a patient's death." The bill would also empower state attorneys general to take back all compensation paid to private equity executives within a decade surrounding the period of financial distress, including salaries, fees, and dividends extracted before the collapse.
Additionally, the bill would require healthcare entities receiving federal funding to disclose ownership changes, investor fees, and debt-to-earnings ratios, or face fines of up to $5 million. It would also prevent real estate investment trusts working in sale-leaseback deals from receiving federal healthcare program payments.
Industry Response
Industry groups have pushed back against the bill, arguing that private equity-backed businesses face the same economic pressures as other companies but have committed investment partners that can provide additional capital and keep investing through difficult periods.
However, the bill's introduction reflects bipartisan momentum for more oversight of the private equity industry. Congress's June 2026 housing bill already curbed private equity investment in single-family homes, and several states are pursuing their own private equity restrictions in healthcare.
What's Next
The bill's introduction marks a significant shift in the regulation of the private equity industry. As the industry continues to face scrutiny, it remains to be seen how private equity firms will respond to the proposed legislation.
With the midterm elections approaching, the momentum for more oversight of the private equity industry is likely to continue. As the industry faces increased scrutiny, it will be essential for investors, policymakers, and healthcare stakeholders to stay informed about the implications of this legislation and its potential impact on the healthcare industry.